What ctDNA, Signatera and studies of exceptional HER2+ responders can … and cannot … tell us about deeper remission and the hope for longer lives.

On losing Dad, the journals we keep, and living with one foot in reality and one in hope.

On World Metastatic Breast Cancer Day, MBC Action Australia shared my story as part of their MBC Hub. I was grateful for the opportunity to talk about my experience of living with Stage 4 breast cancer, and what life looks like beyond a diagnosis that changes everything. I share my story not because I believe it is extraordinary, but because I know how important it is for people living with metastatic breast cancer to see and hear from others navigating the same uncertainty.

A wedding memory, the friendships that have remained, and a reminder that partners have their own journey through cancer too.

A new HER2+ breast cancer approval is a reason for hope. Here’s how FDA decisions can influence access internationally, and why the TGA and PBS still matter in Australia.

A promising therapeutic HER2 vaccine is producing an immune response in early human testing. Here’s what we know so far, and what we don’t.

I stare at my sons more than I used to. They are old enough to notice now.

Recently, on World Cancer Day, I was invited to share publicly a small part of our story, how we told our children about my cancer diagnosis, and why we waited.

The day I learned I had cancer, the life that followed, and why I still choose hope.